needed effects
reteplase
active ingredient
retavase
unwanted side effects
medical attention
following side effects
taking reteplase
check
doctor
nurse
hematologic side effects
reported side effects
inject trial
overall incidence of bleeds from any site
transfusion requirements
inject trial
rapid
trial
types of bleeds
drug
thrombolytic therapy
intracranial hemorrhage
other types of hemorrhage
overall incidence of intracranial hemorrhage
risk
patients with advanced age
hypertension
incidence of transient ischemic attack
tia
reversible ischemic neurologic deficit
rind
inject trial
incidence of frank stroke in the rapid
trial
average incidence of nonintracranial hemorrhage
depending on the trial
use of arterial catheterization
study
us
europe
incidence
site bleeding
venous punctures
serious bleeding in a critical location
retroperitoneal
concomitant heparin
second bolus of reteplase
active ingredient
retavase
incidences
bleeding
following sites within the
following clinical trials
european inject study
n =]
us rapid
study
n =]
european rapid
study
n
injection site
stroke
stroke
anemia
reteplase
lysis of the fibrin plug
bleeding at puncture sites
careful attention
potential sites of bleeding during therapy
injection site
arterial puncture sites
catheter insertion sites
).
following incidences
rapid
trial
myocardial reinfarction
congestive heart failure
ischemia
angina
cholesterol embolization
patients
thrombolytic agents
exact incidence
relationship with lytic therapy
such risk
invasive vascular procedures
cardiac catheterization
angiography
vascular surgery
anticoagulant therapy
reperfusion arrhythmias during thrombolytic therapy
sign of successful lytic therapy
arrhythmias
sinus bradycardia
idioventricular rhythm
ventricular rhythm
ventricular premature depolarizations
ventricular tachycardia
natural course of acute myocardial infarction
standard antiarrhythmic measures
antiarrhythmic therapy for bradycardia
ventricular irritability
reteplase
active ingredient
retavase
therapy
cardiovascular
side effects
sequelae of myocardial infarction
reteplase
side effects
hypotension
cardiogenic shock
arrhythmias
sinus bradycardia
idioventricular rhythm
premature ventricular depolarizations
supraventricular tachycardia
ventricular tachycardia
ventricular fibrillation
av block
pulmonary edema
heart failure
cardiac arrest
recurrent ischemia
reinfarction
myocardial rupture
mitral regurgitation
pericardial effusion
pericarditis
cardiac tamponade
venous thrombosis
embolism
electromechanical dissociation
serious hypersensitivity reactions
reteplase
active ingredient
retavase
patients in the inject trial
such reactions
patients
patient
experiencing dyspnea
hypotension
cases of anaphylaxis
patients
reteplase in initial clinical trials
cases of anaphylaxis
use of reteplase
patients in ongoing clinical trials
data
formation of anti-reteplase antibodies among the
patients
presence of such antibodies
use of reteplase
including
second bolus of reteplase
anaphylaxis
prior use of reteplase in a
given patient
gastrointestinal side effects
nausea
vomiting
fever
general body side effect
side effects of retavase
fda
healthcare professional for medical advice
bleeding at injection site
bleeding from the bladder
blood in urine
tarry stools
severe stomach pain
vomiting of blood
material
coffee grounds
pale skin
troubled breathing with exertion
unusual bleeding
bruising
unusual tiredness
weakness
blurred vision
confusion
cough
breathing
difficulty swallowing
dizziness
faintness
lightheadedness
getting
lying
sitting position
fast heartbeat
hives
itching
puffiness
swelling of the eyelids
eyes
face
lips
tongue
shortness of breath
skin rash
sweating
tightness in chest
wheezing